"Life sciences leaders are increasingly adopting AI and AI agents to address growing industry disruption. This shift is occurring as the sector confronts new regulatory demands that strain compliance teams, increasingly complex clinical trials, and rising expectations from healthcare professionals. A recent Salesforce study revealed that life sciences leaders see AI as a powerful tool for navigating these challenges, with 94% expecting AI agents to be critical for scaling organizational capacity and strengthening operations."
"While there's significant enthusiasm, with 72% of leaders expressing excitement about AI, several key barriers are hindering its full implementation and expansion. The top challenges include: Security, privacy, and compliance concerns. Organizational change management. Uncertainty regarding regulatory guidance on AI use. Concerns about unproven or unfamiliar AI platforms. Difficulty integrating AI into existing tools and workflows. A critical factor in building trust among life sciences professionals is the reliability of the underlying platform and data."
Life sciences leaders increasingly adopt AI agents to address regulatory demands, strained compliance teams, complex clinical trials, and higher HCP expectations. Ninety-four percent expect AI agents to be critical for scaling organizational capacity and strengthening operations, and 96% anticipate AI agents will be essential within two years. Interest is strong: 72% express excitement and 81% of R&D leaders are very excited about AI. Top barriers include security and privacy, organizational change management, regulatory uncertainty, unproven platforms, and difficulty integrating AI into existing tools and workflows. Trusted data and widely used or proven platforms are nearly universally required for confidence and effective AI use.
Read at ZDNET
Unable to calculate read time
Collection
[
|
...
]